These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32665367)

  • 21. Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety.
    Chu DK; Wood RA; French S; Fiocchi A; Jordana M; Waserman S; Brożek JL; Schünemann HJ
    Lancet; 2019 Jun; 393(10187):2222-2232. PubMed ID: 31030987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low dose immunotherapy in very young children to treat peanut allergy.
    Vickery BP
    Expert Rev Clin Immunol; 2016 Dec; 12(12):1251-1253. PubMed ID: 27599211
    [No Abstract]   [Full Text] [Related]  

  • 23. Sublingual immunotherapy for peanut allergy: Long-term follow-up of a randomized multicenter trial.
    Burks AW; Wood RA; Jones SM; Sicherer SH; Fleischer DM; Scurlock AM; Vickery BP; Liu AH; Henning AK; Lindblad R; Dawson P; Plaut M; Sampson HA;
    J Allergy Clin Immunol; 2015 May; 135(5):1240-8.e1-3. PubMed ID: 25656999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modified peanut oral immunotherapy protocol safely and effectively induces desensitization.
    Bird JA; Feldman M; Arneson A; Dougherty I; Brown LS; Burk CM; Kulis M; Burks W; Gill M
    J Allergy Clin Immunol Pract; 2015; 3(3):433-5.e1-3. PubMed ID: 25609341
    [No Abstract]   [Full Text] [Related]  

  • 25. Peanut oral immunotherapy: is it ready for clinical practice?
    Sampson HA
    J Allergy Clin Immunol Pract; 2013 Jan; 1(1):15-21. PubMed ID: 24229817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study protocol of a multicentre, randomised, controlled trial evaluating the effectiveness of probiotic and peanut oral immunotherapy (PPOIT) in inducing desensitisation or tolerance in children with peanut allergy compared with oral immunotherapy (OIT) alone and with placebo (the PPOIT-003 study).
    Chebar Lozinsky A; Loke P; Orsini F; O'Sullivan M; L Prescott S; Gold MS; Quinn P; DunnGalvin A; Lk Tang M;
    BMJ Open; 2020 Sep; 10(9):e035871. PubMed ID: 32912942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-World Experience with Peanut Oral Immunotherapy: Lessons Learned From 270 Patients.
    Wasserman RL; Hague AR; Pence DM; Sugerman RW; Silvers SK; Rolen JG; Herbert M
    J Allergy Clin Immunol Pract; 2019 Feb; 7(2):418-426.e4. PubMed ID: 29859333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peanut Allergy: New Advances and Ongoing Controversies.
    Abrams EM; Chan ES; Sicherer S
    Pediatrics; 2020 May; 145(5):. PubMed ID: 32303583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy, Safety, and Quality of Life in a Multicenter, Randomized, Placebo-Controlled Trial of Low-Dose Peanut Oral Immunotherapy in Children with Peanut Allergy.
    Blumchen K; Trendelenburg V; Ahrens F; Gruebl A; Hamelmann E; Hansen G; Heinzmann A; Nemat K; Holzhauser T; Roeder M; Rosenfeld L; Hartmann O; Niggemann B; Beyer K
    J Allergy Clin Immunol Pract; 2019 Feb; 7(2):479-491.e10. PubMed ID: 30423449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions.
    Wasserman RL; Factor JM; Baker JW; Mansfield LE; Katz Y; Hague AR; Paul MM; Sugerman RW; Lee JO; Lester MR; Mendelson LM; Nacshon L; Levy MB; Goldberg MR; Elizur A
    J Allergy Clin Immunol Pract; 2014; 2(1):91-6. PubMed ID: 24565775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunotherapy for peanut allergy.
    Lee TH; Chan J; Lau VW; Lee WL; Lau PC; Lo MH
    Hong Kong Med J; 2014 Aug; 20(4):325-30. PubMed ID: 24948668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peanut (
    Casale TB; Irani AM
    Expert Rev Clin Immunol; 2023 Mar; 19(3):253-265. PubMed ID: 36524617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transitioning individuals with peanut allergy from US Food and Drug Administration-approved peanut oral immunotherapy to a dietary peanut product.
    Mustafa SS; Shroba J
    Ann Allergy Asthma Immunol; 2023 Jan; 130(1):113-114. PubMed ID: 36210007
    [No Abstract]   [Full Text] [Related]  

  • 34. Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective.
    Vickery BP; Berglund JP; Burk CM; Fine JP; Kim EH; Kim JI; Keet CA; Kulis M; Orgel KG; Guo R; Steele PH; Virkud YV; Ye P; Wright BL; Wood RA; Burks AW
    J Allergy Clin Immunol; 2017 Jan; 139(1):173-181.e8. PubMed ID: 27522159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy.
    Greenhawt M; Sindher SB; Wang J; O'Sullivan M; du Toit G; Kim EH; Albright D; Anvari S; Arends N; Arkwright PD; Bégin P; Blumchen K; Bourrier T; Brown-Whitehorn T; Cassell H; Chan ES; Ciaccio CE; Deschildre A; Divaret-Chauveau A; Dorris SL; Dorsey MJ; Eiwegger T; Erlewyn-Lajeunesse M; Fleischer DM; Ford LS; Garcia-Lloret M; Giovannini-Chami L; Hourihane JO; Jay N; Jones SM; Kerns LA; Kloepfer KM; Leonard S; Lezmi G; Lieberman JA; Lomas J; Makhija M; Parrish C; Peake J; Perrett KP; Petroni D; Pfützner W; Pongracic JA; Quinn P; Robison RG; Sanders G; Schneider L; Sharma HP; Trujillo J; Turner PJ; Tuttle K; Upton JE; Varshney P; Vickery BP; Vogelberg C; Wainstein B; Wood RA; Bee KJ; Campbell DE; Green TD; Rouissi R; Peillon A; Bahnson HT; Bois T; Sampson HA; Burks AW
    N Engl J Med; 2023 May; 388(19):1755-1766. PubMed ID: 37163622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized controlled trial of slow peanut oral immunotherapy in young children: SmaChO study protocol.
    Uhl C; Sverremark-Ekström E; Borres M; Ebisawa M; Melén E; Mäkelä MJ; Konradsen JR; Vickery BP; Asarnoj A; Nilsson C
    Clin Exp Allergy; 2023 May; 53(5):594-597. PubMed ID: 37098849
    [No Abstract]   [Full Text] [Related]  

  • 37. Oral Immunotherapy: An Overview.
    Todoric K; Merrill S
    Prim Care; 2023 Jun; 50(2):269-281. PubMed ID: 37105606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral Immunotherapy for Peanut Allergy.
    Anagnostou K; Clark A
    Annu Rev Med; 2016; 67():375-85. PubMed ID: 26332004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peanut allergen powder (Palforzia).
    Med Lett Drugs Ther; 2020 Mar; 62(1593):33-34. PubMed ID: 32555119
    [No Abstract]   [Full Text] [Related]  

  • 40. Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study.
    Vickery BP; Vereda A; Nilsson C; du Toit G; Shreffler WG; Burks AW; Jones SM; Fernández-Rivas M; Blümchen K; O'B Hourihane J; Beyer K; Anagnostou A; Assa'ad AH; Ben-Shoshan M; Bird JA; Carr TF; Carr WW; Casale TB; Chong HJ; Ciaccio CE; Dorsey MJ; Fineman SM; Fritz SB; Greiner AN; Greos LS; Hampel FC; Ibáñez MD; Jeong DK; Johnston DT; Kachru R; Kim EH; Lanser BJ; Leonard SA; Maier MC; Mansfield LE; Muraro A; Ohayon JA; Oude Elberink JNG; Petroni DH; Pongracic JA; Portnoy JM; Rachid R; Rupp NT; Sanders GM; Sharma HP; Sharma V; Sher ER; Sher L; Sindher SB; Siri D; Spergel JM; Sprikkelman AB; Sussman GL; Tsoumani M; Varshney P; Vitalpur G; Wang J; Yang WH; Zubeldia JM; Smith A; Ryan R; Adelman DC
    J Allergy Clin Immunol Pract; 2021 May; 9(5):1879-1889.e13. PubMed ID: 33359589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.